First Mercantile Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

First Mercantile Trust’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$78K	Sell	443 -21	-5%	-$3.38K	0.01%	719
2021 Q2	$75K	Sell	464 -247	-35%	-$39.7K	0.01%	750
2021 Q1	$122K	Sell	711 -317	-31%	-$62.8K	0.01%	618
2020 Q4	$226K	Sell	1,028 -93	-8%	-$20.1K	0.03%	377
2020 Q3	$255K	Sell	1,121 -381	-25%	-$52.1K	0.03%	317
2020 Q2	$171K	Buy	1,502 +297	+25%	+$28.8K	0.02%	465
2020 Q1	$93K	Buy	1,205 +187	+18%	+$16.8K	0.01%	578
2019 Q4	$131K	Sell	1,018 -151	-13%	-$14.6K	0.02%	598
2019 Q3	$91K	Buy	1,169 +301	+35%	+$28.2K	0.01%	717
2019 Q2	$89K	Buy	+868	New	+$67.6K	0.01%	675
2015 Q4	–	Sell	-4,469	Closed	-$154K	–	986
2015 Q3	$154K	Buy	+4,469	New	+$135K	0.02%	711

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Mercantile Trust's MRTX Position: Q3 2021 in Review

First Mercantile Trust reduced its Mirati Therapeutics, Inc. Common Stock (MRTX) stake by 4.5% in Q3 2021, selling an estimated $3.38K and leaving 443 shares worth $78K. The position accounts for 0.01% of the portfolio, ranked #719.

First Mercantile Trust first reported a position in MRTX in Q3 2015 and has held it in 11 quarters since. The position peaked at $255K in Q3 2020. 238 funds tracked by Wall St. Rank hold MRTX as of Q3 2021.

First Mercantile Trust held 443 shares of Mirati Therapeutics, Inc. Common Stock worth $78K as of Q3 2021.
First Mercantile Trust sold 21 Mirati Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $3.38K.
Mirati Therapeutics, Inc. Common Stock made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #719 holding.
First Mercantile Trust first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2015 and has held it in 11 quarters since.
First Mercantile Trust's Mirati Therapeutics, Inc. Common Stock position peaked at $255K in Q3 2020.
238 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.